Chronic obstructive pulmonary disease (COPD) and asthma are frequent and disabling pathologies. The general practitioner is often at the front line vis-a-vis screening, diagnosis and treatment of these pathologies. There are currently many treatments available, in particular inhaled corticosteroids, and although the recommendations for management appear to be well codified in theory, the adaptation of drug therapy remains complex in general practice. The prescription of inhaled corticosteroids, often initiated during a general medicine consultation, is not simple. The aim of this study is to analyze the relevance of the prescription of inhaled corticosteroids in primary care and to identify the criteria necessary for the prescription of inhaled corticosteroids available in general practice. The main objective of our study is to evaluate the rate of consultations where all the elements required for guiding the prescription of an inhaled corticoid are available. The secondary objectives are: * Identify other factors associated with decision-making * Identify the causes of inhaled corticosteroid stopping (de-prescription)
Study Type
OBSERVATIONAL
Enrollment
80
Cabinet de médecine générale
Clapiers, France
Cabinet de médecine générale
Saint-Martin-de-Londres, France
Presence of all factors justifying the prescription of inhaled cortcoids
The presence (yes/no) of all factors justifying the prescription of inhaled cortcoids as described in the associated market authorization.
Time frame: Day 0 (transversal study)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.